1094 related articles for article (PubMed ID: 26081143)
21. Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson's disease.
Ghosh A; Kanthasamy A; Joseph J; Anantharam V; Srivastava P; Dranka BP; Kalyanaraman B; Kanthasamy AG
J Neuroinflammation; 2012 Oct; 9():241. PubMed ID: 23092448
[TBL] [Abstract][Full Text] [Related]
22. Resveratrol protects dopamine neurons against lipopolysaccharide-induced neurotoxicity through its anti-inflammatory actions.
Zhang F; Shi JS; Zhou H; Wilson B; Hong JS; Gao HM
Mol Pharmacol; 2010 Sep; 78(3):466-77. PubMed ID: 20554604
[TBL] [Abstract][Full Text] [Related]
23. NADPH oxidase and aging drive microglial activation, oxidative stress, and dopaminergic neurodegeneration following systemic LPS administration.
Qin L; Liu Y; Hong JS; Crews FT
Glia; 2013 Jun; 61(6):855-68. PubMed ID: 23536230
[TBL] [Abstract][Full Text] [Related]
24. Discovery of a NADPH oxidase inhibitor, (E)-3-cyclohexyl-5-(4-((2-hydroxyethyl)(methyl)amino)benzylidene)-1-methyl-2-thioxoimidazolidin-4-oneone, as a novel therapeutic for Parkinson's disease.
Shim S; Jeong DU; Kim H; Kim CY; Park H; Jin Y; Kim KM; Lee HJ; Kim DH; Bae YS; Choi Y
Eur J Med Chem; 2022 Dec; 244():114854. PubMed ID: 36274279
[TBL] [Abstract][Full Text] [Related]
25. Effect of the NADPH oxidase inhibitor apocynin on ischemia-reperfusion hippocampus injury in rat brain.
Kapoor M; Sharma N; Sandhir R; Nehru B
Biomed Pharmacother; 2018 Jan; 97():458-472. PubMed ID: 29091896
[TBL] [Abstract][Full Text] [Related]
26. Role and mechanism of microglial activation in iron-induced selective and progressive dopaminergic neurodegeneration.
Zhang W; Yan ZF; Gao JH; Sun L; Huang XY; Liu Z; Yu SY; Cao CJ; Zuo LJ; Chen ZJ; Hu Y; Wang F; Hong JS; Wang XM
Mol Neurobiol; 2014 Jun; 49(3):1153-65. PubMed ID: 24277523
[TBL] [Abstract][Full Text] [Related]
27. NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia.
Qin L; Liu Y; Wang T; Wei SJ; Block ML; Wilson B; Liu B; Hong JS
J Biol Chem; 2004 Jan; 279(2):1415-21. PubMed ID: 14578353
[TBL] [Abstract][Full Text] [Related]
28. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease.
Zhang W; Wang T; Pei Z; Miller DS; Wu X; Block ML; Wilson B; Zhang W; Zhou Y; Hong JS; Zhang J
FASEB J; 2005 Apr; 19(6):533-42. PubMed ID: 15791003
[TBL] [Abstract][Full Text] [Related]
29. Cytotoxicity of paraquat in microglial cells: Involvement of PKCdelta- and ERK1/2-dependent NADPH oxidase.
Miller RL; Sun GY; Sun AY
Brain Res; 2007 Sep; 1167():129-39. PubMed ID: 17662968
[TBL] [Abstract][Full Text] [Related]
30. Blueberry treatment administered before and/or after lipopolysaccharide stimulation attenuates inflammation and oxidative stress in rat microglial cells.
Cahoon DS; Fisher DR; Lamon-Fava S; Wu D; Zheng T; Shukitt-Hale B
Nutr Neurosci; 2023 Feb; 26(2):127-137. PubMed ID: 36692990
[No Abstract] [Full Text] [Related]
31. Fluoxetine prevents MPTP-induced loss of dopaminergic neurons by inhibiting microglial activation.
Chung YC; Kim SR; Park JY; Chung ES; Park KW; Won SY; Bok E; Jin M; Park ES; Yoon SH; Ko HW; Kim YS; Jin BK
Neuropharmacology; 2011 May; 60(6):963-74. PubMed ID: 21288472
[TBL] [Abstract][Full Text] [Related]
32. Activation of neuronal NADPH oxidase NOX2 promotes inflammatory neurodegeneration.
Tu D; Velagapudi R; Gao Y; Hong JS; Zhou H; Gao HM
Free Radic Biol Med; 2023 May; 200():47-58. PubMed ID: 36870375
[TBL] [Abstract][Full Text] [Related]
33. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease.
Zecca L; Wilms H; Geick S; Claasen JH; Brandenburg LO; Holzknecht C; Panizza ML; Zucca FA; Deuschl G; Sievers J; Lucius R
Acta Neuropathol; 2008 Jul; 116(1):47-55. PubMed ID: 18343932
[TBL] [Abstract][Full Text] [Related]
34. Neuroprotective potential of ferulic acid in the rotenone model of Parkinson's disease.
Ojha S; Javed H; Azimullah S; Abul Khair SB; Haque ME
Drug Des Devel Ther; 2015; 9():5499-510. PubMed ID: 26504373
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of Glutaredoxin-1 Activates Microglia and Promotes Neurodegeneration: Implications for Parkinson's Disease.
Gorelenkova Miller O; Behring JB; Siedlak SL; Jiang S; Matsui R; Bachschmid MM; Zhu X; Mieyal JJ
Antioxid Redox Signal; 2016 Dec; 25(18):967-982. PubMed ID: 27224303
[TBL] [Abstract][Full Text] [Related]
36. Histamine induces microglia activation and dopaminergic neuronal toxicity via H1 receptor activation.
Rocha SM; Saraiva T; Cristóvão AC; Ferreira R; Santos T; Esteves M; Saraiva C; Je G; Cortes L; Valero J; Alves G; Klibanov A; Kim YS; Bernardino L
J Neuroinflammation; 2016 Jun; 13(1):137. PubMed ID: 27260166
[TBL] [Abstract][Full Text] [Related]
37. Further Characterization of Intrastriatal Lipopolysaccharide Model of Parkinson's Disease in C57BL/6 Mice.
Deng I; Corrigan F; Garg S; Zhou XF; Bobrovskaya L
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299000
[TBL] [Abstract][Full Text] [Related]
38. Sinomenine, a natural dextrorotatory morphinan analog, is anti-inflammatory and neuroprotective through inhibition of microglial NADPH oxidase.
Qian L; Xu Z; Zhang W; Wilson B; Hong JS; Flood PM
J Neuroinflammation; 2007 Sep; 4():23. PubMed ID: 17880684
[TBL] [Abstract][Full Text] [Related]
39. Role of reactive nitrogen and reactive oxygen species against MPTP neurotoxicity in mice.
Yokoyama H; Takagi S; Watanabe Y; Kato H; Araki T
J Neural Transm (Vienna); 2008 Jun; 115(6):831-42. PubMed ID: 18235988
[TBL] [Abstract][Full Text] [Related]
40. Redox regulation of glial inflammatory response to lipopolysaccharide and interferongamma.
Pawate S; Shen Q; Fan F; Bhat NR
J Neurosci Res; 2004 Aug; 77(4):540-51. PubMed ID: 15264224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
